1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Cold Agglutinin Disease (CAD)- Epidemiology Forecast-2028

Cold Agglutinin Disease (CAD)- Epidemiology Forecast-2028

  • September 2019
  • 91 pages
  • ID: 5816577
  • Format: PDF
  • By Delve Insight

Summary

Table of Contents

‘Cold Agglutinin Disease (CAD)- Epidemiology Forecast-2028’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology trends of CAD in 10 Emerging Markets (EM) i.e. Turkey, Russia, Saudi Arabia, United Arab Emirates (UAE), Mexico, Colombia, Brazil, Argentina, China, and Taiwan.

Geography Covered

• Asia (Taiwan and China)
• Middle East (Saudi Arabia and UAE)
• Eastern Europe (Russia and Turkey)
• LATAM (Mexico, Brazil, Argentina, and Colombia)
Study Period: 2017–2028

CAD - Disease Understanding and Treatment Algorithm

CAD is a type of autoimmune hemolytic anemia (AIHA) which consist of warm, cold, or mixed-reactive antibody types that are directed against antigens on the red blood cell (RBC) surface. The autoantibodies may be idiopathic or related to an underlying condition, such as infection, malignancy, or immune disease.
Thus, based on the autoantibodies, CAD is classified as primary (unknown cause) or secondary (caused by an underlying condition). Primary Cold Agglutinin Disease is used to describe patients without other systemic autoimmune disease or infective etiology and who have no clinical or radiological evidence of underlying lymphoma. Secondary Cold Agglutinin Disease, is mediated by hemolytic anemia occasionally complicating other specific diseases, such as B cell neoplasias (CLL, Waldenstrom macroglobulinemia, myeloma, other lymphomas), solid tumors (squamous carcinoma of the lung, metastatic adenocarcinoma of the colon, basal cell carcinoma, metastatic adrenal carcinoma, mixed parotid tumor), infections (most frequently Mycoplasma pneumonia, Epstein–Barr virus) or autoimmune diseases (scleroderma, primary Sjogren’s syndrome, adult Still’s disease, SLE, rheumatoid arthritis). The responsible antibody is monoclonal IgM in B-cell neoplasias and solid tumors and polyclonal IgM in infections, connective tissue diseases, and non-Hodgkin lymphomas.

CAD Epidemiology

The CAD epidemiology division provides insights about historical and current patient pool and forecasted trends of 10EM countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders (KOL).
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Total Prevalent cases, Gender-Specific Prevalence, Age-Specific Prevalence and Type-Specific Prevalent cases of CAD ) scenario of CAD in 10 Emerging Markets (EM) i.e. Turkey, Russia, Saudi Arabia, United Arab Emirates (UAE), Mexico, Colombia, Brazil, Argentina, China and Taiwan for the study period 2017–2028.
According to the analyst, the total prevalent cases of CAD in the 10EM was found to be 29,077 in 2017. The total prevalent cases for Cold Agglutinin Disease (CAD) were highest in China, while Russia and U.A.E. accounted for the least number of prevalent cases. In the case of Type-Specific cases, Primary CAD and Secondary CAD are reported in nearly equal proportions in all the 10EM countries. However, Primary CAD is commonly observed and easily treated in comparison to secondary CAD. The prevalence of CAD in the 10EM is expected to increase during the study period of 2017-2028.

CAD Report Insights

• The report covers a descriptive overview of the CAD, explaining its signs and symptoms, clonality and histopathology, pathogenesis and diagnosis.
• Comprehensive insight has been provided into the epidemiology CAD in the 10EM countries covering Turkey, Russia, Saudi Arabia, United Arab Emirates (UAE), Mexico, Colombia, Brazil, Argentina, China, and Taiwan.
• Assesses growth opportunities in 10EM countries with respect to the patient population.

CAD Report Key Strengths

• 10-Year Forecast
• 10 EM Coverage
• Epidemiology Segmentation by Type of CAD
• Total Patient Pool of CAD
• Gender-Specific Diagnosed Patient Pool of CAD
• Age-Specific Diagnosed Patient Pool of CAD
• Type-Specific Diagnosed Patient Pool of CAD

CAD Report Assessment

• Current Treatment Practices
• Unmet Needs
• Detailed Pipeline Product Profiles

Key Benefits

• Key assessments

• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by type

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

($3750)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Central Nervous System Disorder Drugs Markets in China

Central Nervous System Disorder Drugs Markets in China

  • $ 4000
  • October 2019

China’s demand for Central Nervous System Disorder Drugs has grown at a fast pace in the past decade.In the next decade, both production and demand will continue to grow. The Chinese economy maintains ...

Anemia Tests - Medical Devices Pipeline Assessment, 2019

Anemia Tests - Medical Devices Pipeline Assessment, 2019

  • $ 2500
  • November 2019

Anemia Tests - Medical Devices Pipeline Assessment, 2019SummaryMedical Devices sector report, “Anemia Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Anemia Tests currently ...

Spain Diagnostics Market Analysis and Forecasts for 500 Tests: Market Shares, Segment Forecasts, Competitive Intelligence, Technology Trends, Emerging Opportunities

Spain Diagnostics Market Analysis and Forecasts for 500 Tests: Market Shares, Segment Forecasts, Competitive Intelligence, Technology Trends, Emerging Opportunities

  • $ 2750
  • October 2019

Spain Diagnostics Market Analysis and Forecasts for 500 Tests: Market Shares, Segment Forecasts, Competitive Intelligence, Technology Trends, Emerging OpportunitiesThis new report provides an overview ...


ref:plp2019

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on